{
  "id": 20551676,
  "title": "China, laboratory of major pharmaceuticals against obesity",
  "url": "https://urgent.news/2026/11/18/china-laboratorio-de-las-grandes-farmaceuticas-contra-la-obesidad",
  "topic": "business",
  "section": "Business",
  "published": "2026-11-18T04:40:00.000Z",
  "source": {
    "name": "El Pais Economia",
    "slug": "el-pais-economia",
    "url": "https://cincodias.elpais.com/opinion/2026-11-18/china-laboratorio-de-las-grandes-farmaceuticas-contra-la-obesidad.html"
  },
  "original_language": "es",
  "account": "Major pharmaceutical companies such as Novo Nordisk and AstraZeneca are turning to China in search of new obesity drugs as many patents are set to expire. China is experiencing a biotechnology boom, with companies ranging from large firms like Jiangsu Hengrui, valued at €42 billion, to start-ups like Rona Therapeutics, which was founded five years ago. These companies are focusing on the growing weight loss market.",
  "summary": "The licenses allow Western groups to access drugs without buying the companies that develop them.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}